Hercules Capital

Hercules is the largest non-bank lender to venture capital-backed companies at all stages of development in a broadly diversified variety of technology, life sciences, and sustainable and renewable technology industries. With over a decade of experience in venture debt, Hercules is uniquely positioned to quickly create innovative financing solutions that perfectly fit within a company's existing capital structure and map to its business objectives. Recognized as the industry leader, Hercules understands the flexibility these types of companies need and has the experience to work closely with them, even through challenging times, to help them reach critical milestones. Hercules' deep sector expertise, geographic presence and its strong capital base have made Hercules the lender of choice for more than 480 innovative companies.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Hercules Capital achieves record performance in 2022, eyes growth opportunities

Hercules Capital's 2022 performance was exceptional, marked by record results and strong credit quality. The company's focus for 2023 includes maintaining a strong balance sheet, disciplined underwriting, and strategic investments. Anticipate increased VC investment activity and an uptick in M&A transactions in the coming year.

Hercules Capital excels in Q1 2023, eyes strategic partnerships

Hercules Capital's Q1 2023 showcased resilience and growth, with strong financial metrics and strategic initiatives. Despite market challenges, the company maintained credit quality and liquidity while exploring opportunities for expansion and partnership enhancement.

Hercules Capital (HTGC) reports record Q2 results and eyes market growth opportunities

Hercules Capital delivered strong Q2 results with record investment income and robust credit quality, showcasing expertise in deal selection and industry diversification.
While facing challenges in meeting earnings expectations and providing detailed diversification insights, the company's strong liquidity and market positioning offer opportunities for future growth and strategic investments.
Overall, Hercules Capital's performance highlights resilience in a dynamic market environment, emphasizing its potential for sustained growth and value creation for investors.

Hercules Capital (HTGC) reports record Q3 earnings and strategic growth

Hercules Capital (HTGC) delivered exceptional financial results in Q3 2023, marked by record earnings and prudent portfolio management.
The company's strategic focus on credit quality, portfolio diversification, and liquidity positions it well for future growth and investment opportunities.
Despite challenges such as asset valuation fluctuations, Hercules Capital remains resilient and poised to capitalize on market dynamics for sustained success.

Hercules Capital reports record Q4 performance and eyes growth opportunities

Hercules Capital (HTGC) delivered strong financial performance in Q4 2023, emphasizing quality, diversification, and growth in key sectors like life sciences.
While challenges exist in managing expenses and optimizing capital efficiency, the company's conservative approach and liquidity position provide a solid foundation for future success.
Opportunities lie in expanding the venture and growth stage asset class, driving platform growth, and engaging with investors at upcoming conferences.

Hercules Capital excels in Q1 2024, poised for strategic growth

Hercules Capital delivered exceptional performance in Q1 2024, with record origination and funding, strong investment income, improved credit quality, and robust liquidity, positioning the company for continued success.
The company's strengths lie in its solid balance sheet, under-levered position, focus on quality growth, and favorable standing with rating agencies, providing a strong foundation for future growth.
Challenges include managing leverage increase, debt refinancing, maintaining credit quality standards, and navigating market uncertainties, requiring strategic planning and risk management.
Opportunities for Hercules include leveraging its milestone anniversary, expanding investor base through conferences, exploring new investments, and driving sustainable growth through prudent strategies.

Hercules Capital posts record Q2 results amidst market volatility

Hercules Capital delivered a strong performance in Q2 2024, marked by record fundings and asset growth, despite anticipating increased market volatility ahead.
The company's focus on credit quality, liquidity, and diversification through SBIC licenses strengthens their resilience and growth prospects.
While facing challenges such as market volatility and prepayment expectations, Hercules Capital remains well-positioned to leverage opportunities and navigate uncertainties.

Hercules Capital (HTGC) reports record Q3 earnings amidst market challenges

Hercules Capital (HTGC) reported strong financial performance in Q3 with record total investment income and NII, despite challenges in the venture capital ecosystem.
Maintaining a defensive balance sheet approach and strong liquidity, Hercules is well-positioned to navigate market uncertainties and capitalize on growth opportunities.
While facing challenges from market slowdowns, Hercules' prudent underwriting and commitment to shareholder returns showcase resilience and long-term stability.
With opportunities arising from increased funding activity post-Fed rate action and pending commitments, Hercules is poised for potential growth in Q4 and beyond.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Hercules Capital, Inc. is a specialty finance company, which focuses on providing senior secured loans to high-growth, innovative venture capital-backed companies in a variety of technology, life sciences, and sustainable and renewable technology industries. The company was founded by Manuel A. Henriquez in December 2003 and is headquartered in Palo Alto, CA.

Hanmi Financial

Sixth Street Specialty Lending

In the past month with the Russell 2000 index up roughly 7%, as compared to the S&P 500 index up nearly 4.8%, it is evident that small cap stocks are leading the charge in this bear market rally. The WisdomTree U.S.

As Small Caps Rally, These 3 Finance High-Yielders Could Have Further Upside - WisdomTree U.S. SmallCap Dividend Fund (ARCA:DES), Hanmi Financial (NASDAQ:HAFC)

Tricida Inc

Tricida Announces $125 Million Debt Facility with Hercules Capital

Hercules Capital Announces Date for Release of Third Quarter 2022 Financial Results and Conference Call

Hercules Capital Announces Supplemental Cash Distribution of $0.15 per Share for the Third Quarter of 2022

Hercules Capital Increases Its Quarterly Cash Distribution to $0.36 per Share for the Third Quarter of 2022

Hercules Capital offers investors a high yield plus growth. Portfolio is diversified and focuses on recession-proof business sectors.

Hercules Capital: I Am Happily Buying This Covered 12.41% Yield

Hercules Capital has been hammered as it remains nearly 40% below its April 2022 highs. We believe the de-rating is justified to de-risk the execution risks in its tech-focused portfolio companies. However, long-term investors need to ask whether the battering in HTGC is sufficient to justify adding exposure at the current levels. We discuss the critical metrics for investors to assess.

Hercules Capital: Grab Its 13% Yield As Weak Holders Capitulate

Hercules Capital is an attractive, 11.5% yielding, internally-managed BDC with a differentiated strategy and a track record of success. However the shares have sold off hard, and there are significant risk factors to consider.

Hercules 11.5% Yield: 40 Big-Dividend BDCs Compared

Provention Bio Inc

RED BANK, N.J. , Aug. 31, 2022 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB) (the "Company"), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today announced that the Company has secured a term loan facility of up to $125 million with Hercules Capital, Inc. (NYSE: HTGC), a leader in customized financing for companies in life sciences.

Provention Bio Announces $125 Million Term Loan Facility with Hercules Capital

Hercules Capital is a well-run lender to high-growth companies, with a focus on technology and life sciences companies. The company has been able to grow its originations and portfolio while maintaining strong credit quality.

Hercules Capital: 10% Yield, Wake Up And Smell The Cash Flow

Ares Capital

Barings BDC Inc

Capital Southwest

FS KKR Capital Corp

Oaktree Specialty Lending

Interest rates are headed higher, and despite chatter that the Federal Reserve efforts may slow in September, that will depend on when inflation decides to pause.

6 ‘Strong Buy' Commercial Finance Stocks That Pay Generous and Dependable Dividends

Hercules Capital has a rare mispriced issue with a YTM of 7%. Recently reviewed credit rating.

Hercules Capital: 7% From An Investment Grade Bond With 4 Years To Maturity

Golub Capital BDC

Higher rates, decent economic growth, robust asset quality and regulatory changes will keep aiding the Zacks SBIC & commercial finance industry players like Ares Capital (ARCC), Golub Capital (GBDC) and Hercules Capital (HTGC).

3 Stocks From the Thriving SBIC & Commercial Finance Industry

Driven by the growing demand for customized financing, Hercules Capital's (HTGC) top line is expected to keep improving.

Robust Loan Originations Aid Hercules Capital (HTGC) Top Line

Hercules Capital's portfolio kept performing extremely well in 2Q-22. Non-accruals remained at a very low level.

Hercules Capital: I Am Getting A 10.9% Yield On My Latest Buy

Hercules Capital just raised its upcoming dividend by 6%, to $.32. It'll also pay a $.15 supplemental dividend again in August.

Hercules Capital: Good Q2 Earnings, 12% Yield, 6% Dividend Hike

Hercules Capital (HTGC) records a rise in total investment income and expenses in the second quarter of 2022.

Hercules Capital (HTGC) Q2 Earnings Miss, Revenues Rise Y/Y

Hercules Capital, Inc. (NYSE:HTGC ) Q2 2022 Earnings Conference Call July 28, 2022 5:00 PM ET Company Participants Michael Hara - IR and Corporate Communications Scott Bluestein - CEO and Chief Investment Officer Seth Meyer - CFO Conference Call Participants Crispin Love - Piper Sandler Kevin Fultz - JMP Securities Christopher Nolan - Ladenburg Thalmann Ryan Lynch - KBW Kenneth Lee - RBC Capital Markets Casey Alexander - Compass Point Operator Good day, ladies and gentlemen, and thank you for standing by. Welcome to the Hercules Capital Second Quarter 2022 Earnings Conference Call.

Hercules Capital, Inc. (HTGC) CEO Scott Bluestein on Q2 2022 Results - Earnings Call Transcript

Hercules Tech (HTGC) delivered earnings and revenue surprises of -3.03% and 0.18%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Hercules Technology (HTGC) Q2 Earnings Lag Estimates

PALO ALTO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced its financial results for the second quarter ended June 30, 2022. The earnings release can be accessed at Hercules' Investor Relations website at https://investor.htgc.com/f

Hercules Capital Reports Second Quarter 2022 Financial Results

IVERIC bio Inc

PARSIPPANY, N.J.--(BUSINESS WIRE)--Iveric Bio announced that it has entered into a term loan debt financing facility with Hercules Capital, Inc. and Silicon Valley Bank.

Iveric Bio Announces Agreement for Up to $250 Million in Non-Dilutive Debt Financing with Hercules Capital and Silicon Valley Bank

PALO ALTO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declared a supplemental cash distribution of $0.15 per share. This supplemental cash distribution will be paid out of Hercules Capital

Hercules Capital Announces Supplemental Cash Distribution of $0.15 per Share for the Second Quarter of 2022

PALO ALTO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty finance provider to innovative, venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has increased and declared a second quarter 2022 cash distribution of $0.35 per share. The following shows the key dates of the second quar

Hercules Capital Increases Its Quarterly Cash Distribution to $0.35 per Share for the Second Quarter of 2022

Trinity Capital

In recent years, ARKK has become an extremely popular choice among investors for exposure to innovative tech. But there are other, arguably superior, ways to gain exposure to these types of innovative companies.

Forget ARKK ETF: Invest In Innovative Tech With These 2 High Yielders

Apollo Investment

Blackstone Secured Lending Fund

TCG BDC

Fidus Investment

Gladstone Investment

Gladstone Capital

Goldman Sachs BDC

Main Street Capital

Monroe Capital

Owl Rock Capital Corp

PennantPark Floating Rate Capital

PennantPark Investment

Prospect Capital

TCP Capital

Triplepoint Venture Growth BDC

This should be excellent timing for a discussion of investment grade (“IG”) notes/bonds for lower-risk investors that do not mind lower yields/returns. These notes were previously overpriced, but prices have declined and are now at attractive levels, most of which are yielding between 5% and 8%.

News for Hercules Capital ETF (HTGC)